Abstract
"/Borrelia////miyamotoi/ disease (BMD) is a newly recognized borreliosis
globally transmitted by ticks of the Ixodes persulcatus species complex.
Once considered to be a tick symbiont with no public health
implications, B miyamotoi is increasingly recognized as the agent of a
nonspecific febrile illness often misdiagnosed as acute Lyme disease
without rash, or as ehrlichiosis. The frequency of its diagnosis in the
northeastern United States is similar to that of human granulocytic
ehrlichiosis.
A diagnosis of BMD is confirmed by polymerase chain reaction analysis of
acute blood samples, or by seroconversion using a recombinant
glycerophosphodiester phosphodiesterase enzyme immunoassay.
BMD is successfully treated with oral doxycycline or amoxicillin."
dx.doi.org/10.1016/j.cll.2015.08.002